Leukemia

Showing NaN - NaN of 143

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Myelodysplastic Syndrome Trial in Boston (Bortezomib, Tacrolimus, Methotrexate)

Completed
  • Leukemia
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 23, 2017

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 20, 2017

Chemotherapy or Malignancy-Induced Hyperuricemia in

Completed
  • Leukemia
  • +3 more
  • Palo Alto, California
  • +10 more
Apr 24, 2017

GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 30, 2017

Leukemia Trial in Worldwide (biological, drug, radiation)

Completed
  • Leukemia
  • filgrastim
  • +12 more
  • Birmingham, Alabama
  • +152 more
Feb 14, 2017

Leukemia Trial in United States (cytarabine, idarubicin, lestaurtinib)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +20 more
Feb 7, 2017

Patients With Chronic Myelogenous Leukemia

Completed
  • Leukemia
    • Boston, Massachusetts
      Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institut
    Dec 30, 2016

    Leukemia Trial in United States (rituximab, fludarabine phosphate)

    Completed
    • Leukemia
    • rituximab
    • fludarabine phosphate
    • La Jolla, California
    • +33 more
    Jul 19, 2016

    Leukemia, MDS Trial in United States (topotecan HCl)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • topotecan hydrochloride
    • Birmingham, Alabama
    • +47 more
    Jul 19, 2016

    Leukemia Trial in Puerto Rico, United States (ara-C, gemtuzumab ozogamicin)

    Completed
    • Leukemia
    • Anniston, Alabama
    • +77 more
    Jul 12, 2016

    Leukemia Trial in United States (alemtuzumab, fludarabine phosphate)

    Completed
    • Leukemia
    • alemtuzumab
    • fludarabine phosphate
    • Birmingham, Alabama
    • +49 more
    Jul 1, 2016

    Leukemia Trial in United States (G-CSF, asparaginase, cyclophosphamide)

    Completed
    • Leukemia
    • G-CSF
    • +10 more
    • Birmingham, Alabama
    • +49 more
    Jul 1, 2016

    Leukemia Trial in United States (hydroxyurea, Homoharringtonine)

    Terminated
    • Leukemia
    • Birmingham, Alabama
    • +132 more
    Jul 1, 2016

    Gene Alterations in Patients With Acute Myeloid Leukemia

    Completed
    • Leukemia
    • reverse transcriptase-polymerase chain reaction
    • Birmingham, Alabama
    • +45 more
    Jul 1, 2016

    Leukemia Trial in Worldwide (Bendamustine)

    Completed
    • Leukemia
    • Orange, California
    • +49 more
    Apr 21, 2016

    Leukemia Trial in Worldwide (cyclophosphamide, cytarabine, daunorubicin HCl)

    Completed
    • Leukemia
    • Birmingham, Alabama
    • +122 more
    May 11, 2016

    Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (sequential cord blood transplantation)

    Completed
    • Lymphoma
    • +3 more
    • sequential cord blood transplantation
    • Boston, Massachusetts
    • +1 more
    May 9, 2016

    Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation Trial in United States (fluconazole,

    Completed
    • Bone Marrow Transplantation
    • +6 more
    • Duarte, California
    • +15 more
    Feb 17, 2016

    Leukemia Trial in Worldwide (Dasatinib, Imatinib)

    Completed
    • Leukemia
    • Anaheim, California
    • +71 more
    Dec 16, 2015

    Kidney Cancer, Leukemia, Lymphoma Trial in Worldwide (Traumeel S, Placebo)

    Completed
    • Kidney Cancer
    • +5 more
    • Traumeel S
    • Placebo
    • Birmingham, Alabama
    • +43 more
    Jan 5, 2016

    Leukemia Trial in Boston, Portland (cytarabine, imatinib mesylate)

    Terminated
    • Leukemia
    • Boston, Massachusetts
    • +1 more
    Dec 8, 2015

    Leukemia Trial in Canada, Sweden, United States (gemtuzumab ozogamicin, observation, Cytosine arabinoside)

    Completed
    • Leukemia
    • gemtuzumab ozogamicin
    • +3 more
    • Anchorage, Alaska
    • +278 more
    Sep 25, 2015

    Leukemia, MDS Trial in Israel, United States (filgrastim, sargramostim, cytarabine)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • filgrastim
    • +5 more
    • Scottsdale, Arizona
    • +91 more
    Jun 1, 2015

    Leukemia Trial in Worldwide (questionnaire administration)

    Completed
    • Leukemia
    • questionnaire administration
    • Birmingham, Alabama
    • +121 more
    May 6, 2015